Journal of Cancer Research and Therapeutics Close
 

Table 2 :Multivariate analysis of hazards ratios of renal impairment for zoledronic acid vs. ibandronate after adjusting for significant covariates

Table 2 :Multivariate analysis of hazards ratios of renal impairment for zoledronic acid vs. ibandronate after adjusting for significant covariates